艾德生物：关于2025年前三季度计提资产减值准备的公告

Core Viewpoint - The company, Aide Biological, announced a provision for asset impairment totaling 26.83 million yuan based on prudent principles, indicating potential signs of impairment in receivables and other assets as of September 30, 2025 [1] Group 1 - The company conducted impairment testing on its consolidated financial statements, including notes receivable, accounts receivable, other receivables, and long-term receivables [1] - The total amount of asset impairment provision for the first three quarters of 2025 is 26.83 million yuan [1]